Literature DB >> 30476174

CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient.

Anna Luisa Di Stefano1,2, Julien Savatovsky3, Loic Feuvret4, Chiara Villa5, Vincent Reina6, Micheline Pha7, Caroline Houillier8, Giulia Berzero9, Ahmed Idbaih8, Dimitri Psimaras8.   

Abstract

Entities:  

Year:  2019        PMID： 30476174      PMCID： PMC6303433          DOI： 10.1093/neuonc/noy168

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

1.  Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.

Authors:  Edward J Gettings; Christopher T Hackett; Thomas F Scott
Journal:  Mult Scler       Date:  2014-09-25       Impact factor: 6.312

Review 2.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

3.  Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience.

Authors:  Robert C Miller; Daniel H Lachance; Claudia F Lucchinetti; B Mark Keegan; Ralitza H Gavrilova; Paul D Brown; Brian G Weinshenker; Moses Rodriguez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-11       Impact factor: 7.038

Review 4.  Neurological toxicities associated with immune-checkpoint inhibitors.

Authors:  Mehdi Touat; Daniel Talmasov; Damien Ricard; Dimitri Psimaras
Journal:  Curr Opin Neurol       Date:  2017-12       Impact factor: 5.710

Review 5.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

Authors:  M J van den Bent; J S Wefel; D Schiff; M J B Taphoorn; K Jaeckle; L Junck; T Armstrong; A Choucair; A D Waldman; T Gorlia; M Chamberlain; B G Baumert; M A Vogelbaum; D R Macdonald; D A Reardon; P Y Wen; S M Chang; A H Jacobs
Journal:  Lancet Oncol       Date:  2011-04-05       Impact factor: 41.316

6.  Acute demyelination following radiotherapy for glioma: a cautionary tale.

Authors:  Marina Milic; Jeremy H Rees
Journal:  Pract Neurol       Date:  2016-09-09
  6 in total
  1 in total

Review 1.  Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR).

Authors:  Suki Gill; Anna K Nowak; Samantha Bowyer; Raelene Endersby; Martin A Ebert; Alistair Cook
Journal:  J Med Imaging Radiat Oncol       Date:  2022-06-14       Impact factor: 1.667
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.